自然产品的提取,表征和生物活动
Linlin Yan1, Aleksandra Cvetanović Kljakić2
1Institute of Chemical Industry of Forest Products, CAF, Nanjing 210042, China.
Plants (Basel, Switzerland)
|October 14, 2023
概括
本特别号探讨了天然产品的提取,表征和生物活性. 它强调了近期科学进展,即从植物中分离出活性化合物.
科学领域:
- 自然产品化学 自然产品化学
- 药物鉴定学是指药物鉴定学.
- 植物化学 植物化学
背景情况:
- 专注于从天然植物来源提取,分离和表征生物活性化合物.
- 旨在加深对当前科学方法和现场发现的理解.
- 强调自然产品在各种科学和医疗应用中的重要性.
研究的目的:
- 介绍自然产品研究中最新的科学进展.
- 为了加深对提取和表征方法的理解.
- 探索来自自然来源的化合物的生物活动.
主要方法:
- 先进的提取技术用于分离植物化合物.
- 谱学和染色学方法用于表征.
- 在体外和体内测试以确定生物活性.
主要成果:
- 识别来自各种植物物种的新生物活性化合物.
- 阐明生物活动背后的机制.
- 通过科学证据验证药用植物的传统用途.
结论:
- 自然产品继续成为新疗法剂的重要资源.
- 对提取和表征的进一步研究将产生更多的发现.
- 了解生物活动是利用自然产品潜力的关键.
更多相关视频
相关概念视频
Structure-Activity Relationships and Drug Design
737
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
737
Drug Discovery: Overview
8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K
Extraction: Advanced Methods
466
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
466


